Literature DB >> 9822868

Diblock copolymer nanoparticles for drug delivery.

G S Kwon1.   

Abstract

Diblock copolymers can form nanoparticles, that is, micelles and nanospheres, that are being studied as carriers for hydrophobic drugs and genes. The synthetic carriers mimic the spherical, supramolecular core/shell structure of lipoproteins and viruses. Hence, diblock copolymer nanoparticles may be functional, having the ability to solubilize, protect, and release drugs at sustained rates. Several studies have illustrated prolonged residence times in blood for diblock copolymer nanoparticles. They have also enhanced drug effects in animals. Diblock copolymer nanoparticles are potentially useful carriers for site-specific drug delivery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822868

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  13 in total

Review 1.  Disposition of drugs in block copolymer micelle delivery systems: from discovery to recovery.

Authors:  Hamidreza Montazeri Aliabadi; Mostafa Shahin; Dion R Brocks; Afsaneh Lavasanifar
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

2.  Flash nanoprecipitation: particle structure and stability.

Authors:  Kevin M Pustulka; Adam R Wohl; Han Seung Lee; Andrew R Michel; Jing Han; Thomas R Hoye; Alon V McCormick; Jayanth Panyam; Christopher W Macosko
Journal:  Mol Pharm       Date:  2013-10-15       Impact factor: 4.939

3.  Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice.

Authors:  Anatoly N Lukyanov; Zhonggao Gao; Laureen Mazzola; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

Review 4.  Micellar nanocarriers: pharmaceutical perspectives.

Authors:  V P Torchilin
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.200

5.  Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats.

Authors:  May P Xiong; Jaime A Yáñez; Connie M Remsberg; Yusuke Ohgami; Glen S Kwon; Neal M Davies; M Laird Forrest
Journal:  J Control Release       Date:  2008-03-25       Impact factor: 9.776

6.  Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles.

Authors:  Peisheng Xu; Edward A Van Kirk; William J Murdoch; Yihong Zhan; Dale D Isaak; Maciej Radosz; Youqing Shen
Journal:  Biomacromolecules       Date:  2006-03       Impact factor: 6.988

7.  A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats.

Authors:  May P Xiong; Jaime A Yáñez; Glen S Kwon; Neal M Davies; M Laird Forrest
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

8.  Preparation and drug loading of poly(ethylene glycol)-block-poly(epsilon-caprolactone) micelles through the evaporation of a cosolvent azeotrope.

Authors:  Karen K Jette; Devalina Law; Eric A Schmitt; Glen S Kwon
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

Review 9.  Degradation of Drug Delivery Nanocarriers and Payload Release: A Review of Physical Methods for Tracing Nanocarrier Biological Fate.

Authors:  Patrick M Perrigue; Richard A Murray; Angelika Mielcarek; Agata Henschke; Sergio E Moya
Journal:  Pharmaceutics       Date:  2021-05-21       Impact factor: 6.321

10.  Fabrication and intracellular delivery of doxorubicin/carbonate apatite nanocomposites: effect on growth retardation of established colon tumor.

Authors:  Sharif Hossain; Hirofumi Yamamoto; Ezharul Hoque Chowdhury; Xin Wu; Hajime Hirose; Amranul Haque; Yuichiro Doki; Masaki Mori; Toshihiro Akaike
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.